![FDA Resumes Pre-Submission Requests for Non-COVID-19 IVD Tests](https://www.g2intelligence.com/wp-content/uploads/2022/06/June13-2022.News_.FDAPremarket-iStock-1800x1250-1-1080x675.jpg)
FDA Resumes Pre-Submission Requests for Non-COVID-19 IVD Tests
Effective June 1, the agency is once more accepting pre-submission requests for all in vitro diagnostics, including non-COVID-19 tests.
Effective June 1, the agency is once more accepting pre-submission requests for all in vitro diagnostics, including non-COVID-19 tests.
If your lab received federal relief funds from the US government during the COVID-19 pandemic, you could be at risk of FCA lawsuits.
The company has successfully completed clinical trials in Israel on more than 300 women and is applying for CE marking and FDA approval.
New research shows cancer screening prevalence declined in 2020 compared to 2018, though not for all cancer types studied.
White House releases an update on the progress of the initiative to provide equitable access to COVID-19 testing and treatments in the US.